Announcement of Lease Transaction Transfer: Information Disclosure of Two Property Rental Projects of Harbin Pharmaceutical Group Pharmaceutical Co., Ltd. [Information Time: May 20, 2025] Reading Times: Project Name: Harbin Pharmaceutical Group Pharmaceutical Co., Ltd. Two Property Rental Project Number: [2025] Harbin Property Rental 119 Listing Start Date: May 20, 2025 Listing Deadline: May 29, 2025 Lessor Application and Commitment&Ensp;   The lessor intends to lease the assets or resources it holds and entrusts the Harbin Property Rights Exchange to publicly disclose information on property leasing and organize trading activities. In accordance with the principles of openness, fairness, impartiality, and integrity, the following commitments are made: 1. This rental behavior is a true expression of the lessor's intention, and the ownership of the leased subject matter is clear. The lessor has full disposal rights over the subject matter and there are no restrictions on its implementation. 2. The lessor's leasing of assets or resources has followed the relevant procedures and complied with the requirements of relevant laws and regulations. After effective internal decision-making, it has obtained relevant approvals from the resource management department and state-owned asset supervision agency. 3. The rental announcement and attachment materials submitted by the lessor are true, complete, legal, and valid, without any false records, misleading statements, or significant omissions. 4. The lessor shall comply with laws and regulations and relevant rules of the property rights trading market during the rental process, and fulfill the obligations of the lessor in accordance with relevant requirements. The lessor guarantees to abide by the above commitments. If any breach of the above commitments or violation of regulations causes losses to the parties involved in the transaction, we are willing to bear legal responsibility and corresponding economic compensation liability.   Overview of the subject matter for rent, subject matter name, subject matter 2: Harbin Pharmaceutical Group Pharmaceutical Co., Ltd., 33 Nanping Street, Daowai District, storefront, subject matter status, subject matter type, property ownership certificate number    Ownership owner: Harbin Pharmaceutical Group Pharmaceutical Co., Ltd., located at No. 33 Nanping Street, Daowai District. The reference building area is 126 square meters and the number of floors is 8/1. The risk deposit is 15000 yuan. The lease term is 3 years. The priority right of the original lessee is evaluated. The current use of the commercial service is the current condition of the lease (the original contract expires on March 20, 2025). The rental increase method is for the rental of ancillary facilities. The base price for rental is 260300 yuan per year. The rental evaluation is based on the Ensp;         On the benchmark date of December 9, 2024, February 24, 2025, the evaluation agency's evaluation report number is Hei Zhong Ji Ji Ping Zi [2024] No. 220, Hei Zhong Ji Ji Ping Zi [2025] No. 032. The list of approved or filed agency targets can be found in the attached download: detailed explanation of rental defects, major issues, and other contents that need to be disclosed. 1. The scope of this lease is subject to the Hei Zhong Ji Ji Ping Zi [2024] No. 220 and Hei Zhong Ji Ji Ping Zi [2025] No. 032 evaluation reports issued by Heilongjiang Zhongrong Real Estate Land Asset Evaluation Co., Ltd. Although they have been evaluated by qualified evaluation agencies, the relevant information may be incorrect and is for reference only. 2. The intended lessee shall conduct a thorough on-site inspection during the announcement period to assess the legal, natural, and safety conditions of the leased property